MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong
· Delayed Price · Currency is HKD 7.97
-0.01 (-0.13%)
Apr 29, 2026, 4:08 PM HKT
HKG:2235 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Operating Revenue | 660.79 | 340.35 | 248.35 | 169.89 | 151.4 | Upgrade
|
| Other Revenue | - | 5.26 | 4.88 | 3.72 | - | Upgrade
|
| Revenue | 660.79 | 345.62 | 253.23 | 173.61 | 151.4 | Upgrade
|
| Revenue Growth (YoY) | 91.19% | 36.48% | 45.86% | 14.67% | 101.13% | Upgrade
|
| Cost of Revenue | 303.36 | 166.54 | 136.08 | 93.91 | 80.52 | Upgrade
|
| Gross Profit | 357.42 | 179.08 | 117.14 | 79.69 | 70.88 | Upgrade
|
| Selling, General & Admin | 271.34 | 249.28 | 250.62 | 158.23 | 93.74 | Upgrade
|
| Research & Development | 76.34 | 76.56 | 70.1 | 61.09 | 36.08 | Upgrade
|
| Other Operating Expenses | -9.61 | -0.79 | -9.28 | -21.99 | - | Upgrade
|
| Operating Expenses | 339.61 | 326.49 | 312.43 | 200.04 | 131.05 | Upgrade
|
| Operating Income | 17.82 | -147.41 | -195.29 | -120.34 | -60.17 | Upgrade
|
| Interest Expense | -0.13 | -0.68 | -0.05 | -0.15 | -0.02 | Upgrade
|
| Interest & Investment Income | 53.9 | 64.25 | 68.24 | 55.72 | 24.49 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 9.7 | 7.11 | 29.95 | -16.48 | Upgrade
|
| Other Non Operating Income (Expenses) | -22.04 | -0.3 | -4.68 | -0.22 | 3.97 | Upgrade
|
| EBT Excluding Unusual Items | 49.55 | -74.44 | -124.67 | -35.03 | -48.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.03 | 0.09 | -0.02 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | - | - | -0.01 | 0.05 | Upgrade
|
| Asset Writedown | -9.12 | -0.83 | -0.16 | -0 | - | Upgrade
|
| Other Unusual Items | - | 12.03 | 0 | - | - | Upgrade
|
| Pretax Income | 40.4 | -63.15 | -124.85 | -35.04 | -48.15 | Upgrade
|
| Income Tax Expense | 0.25 | -0.03 | 0.16 | 0 | - | Upgrade
|
| Earnings From Continuing Operations | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 | Upgrade
|
| Net Income | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 | Upgrade
|
| Net Income to Common | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 | Upgrade
|
| Shares Outstanding (Basic) | 402 | 418 | 431 | 438 | 373 | Upgrade
|
| Shares Outstanding (Diluted) | 402 | 418 | 431 | 438 | 373 | Upgrade
|
| Shares Change (YoY) | -3.93% | -3.05% | -1.59% | 17.39% | 21.79% | Upgrade
|
| EPS (Basic) | 0.10 | -0.15 | -0.29 | -0.08 | -0.13 | Upgrade
|
| EPS (Diluted) | 0.10 | -0.15 | -0.29 | -0.08 | -0.13 | Upgrade
|
| Free Cash Flow | - | -120.65 | -153 | -148.79 | -61.82 | Upgrade
|
| Free Cash Flow Per Share | - | -0.29 | -0.35 | -0.34 | -0.17 | Upgrade
|
| Gross Margin | 54.09% | 51.81% | 46.26% | 45.91% | 46.82% | Upgrade
|
| Operating Margin | 2.70% | -42.65% | -77.12% | -69.32% | -39.74% | Upgrade
|
| Profit Margin | 6.08% | -18.26% | -49.37% | -20.18% | -31.80% | Upgrade
|
| Free Cash Flow Margin | - | -34.91% | -60.42% | -85.71% | -40.83% | Upgrade
|
| EBITDA | 29.02 | -136.21 | -184.12 | -110.19 | -52.28 | Upgrade
|
| EBITDA Margin | 4.39% | -39.41% | -72.71% | -63.47% | -34.53% | Upgrade
|
| D&A For EBITDA | 11.2 | 11.2 | 11.17 | 10.15 | 7.88 | Upgrade
|
| EBIT | 17.82 | -147.41 | -195.29 | -120.34 | -60.17 | Upgrade
|
| EBIT Margin | 2.70% | -42.65% | -77.12% | -69.32% | -39.74% | Upgrade
|
| Effective Tax Rate | 0.62% | - | - | - | - | Upgrade
|
| Revenue as Reported | - | 345.62 | 253.23 | 173.61 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.